Login to Your Account

Acea's $30M series A to boost pipeline, drug discovery tool business

By Shannon Ellis
Staff Writer

Tuesday, November 10, 2015

SHANGHAI – Acea Biosciences Inc., a company that got its start selling instruments used for drug discovery and along the way developed its own pipeline of novel drug compounds, has just closed its first venture round, receiving $30 million from Lilly Asia Ventures and Qiming Venture Partners.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription